Skip to Content
Merck
  • Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents.

Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents.

Contrast media & molecular imaging (2009-10-20)
Eric J Werner, Mauro Botta, Silvio Aime, Kenneth N Raymond
ABSTRACT

A series of new Gd(III) hydroxypyridonate complexes featuring a mesitylene (ME)-derived ligand cap has been prepared. Relaxometric characterization reveals that the complexes tend to form large aggregates in solution with slow tumbling rates, as estimated from NMRD analysis, and unique pH-dependent relaxivities. The solution behavior and relaxometric properties are compared with those observed for analogous TREN-capped compounds, and the potential for use of these new ME-capped complexes as pH-responsive MRI contrast agents is explored.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Mesitylene, reagent grade, 97%
Sigma-Aldrich
Mesitylene, 98%
Supelco
Mesitylene, analytical standard